Tags: Drug.
Artesunate/amodiaquine (trade name Coarsucam) is a fixed-dose artemisinin-based combination therapy (ACT) indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria.It was launched in 2007 as an affordable treatment for malaria devised by DNDi in partnership with Sanofi-Aventis.The drug is patent free.Early clinical trials showed that a once-a-day dosage was effective.